Article
CYP2B6 and OPRM1 Receptor Polymorphisms at Methadone Clinics And Novel OPRM1 Haplotypes: A Cross-Sectional Study.
Drug metabolism letters - 1 Jan 2016
AlMeman Ahmad Abdulrahman, Ismail Rusli, Perola Markus
Abstract excerpt
INTRODUCTION: Methadone is accepted as an alternative therapy in opioid use disorders worldwide. Methadone responsiveness, however, is affected by a range of CYP450 enzymes and OPRM1 polymorphisms. OBJECTIVE: This study sought to detect CYP2B6 and OPRM1 variants and their genotypes, as major contributors to inter-variability in methadone responsiveness and methadone dose requirements. METHODS: We carried out a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
